$IBRX
ImmunityBio, Inc.

2016 Q4 Form 10-Q Financial Statement

#000156459016028905 Filed on November 10, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q3
Revenue $14.00K $12.00K $10.00K
YoY Change -6.67% 20.0% -92.48%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $15.71M $24.42M $41.81M
YoY Change -39.2% -41.59% 5674.86%
% of Gross Profit
Research & Development $9.450M $8.360M $3.950M
YoY Change 84.93% 111.65% 1104.27%
% of Gross Profit
Depreciation & Amortization $1.840M $300.0K -$10.00K
YoY Change 275.51% -3100.0% -120.0%
% of Gross Profit
Operating Expenses $25.16M $32.79M $46.47M
YoY Change -15.97% -29.44% 4317.02%
Operating Profit -$25.14M -$32.78M -$46.46M
YoY Change -15.97% -29.45% 4955.17%
Interest Expense $1.370M $29.00K $0.00
YoY Change -52.6%
% of Operating Profit
Other Income/Expense, Net -$620.0K $826.0K $145.0K
YoY Change 588.89% 469.66% 14400.0%
Pretax Income -$24.39M -$31.95M -$46.31M
YoY Change -68.37% -31.01% 5068.75%
Income Tax -$150.0K -$52.00K $0.00
% Of Pretax Income
Net Earnings -$24.24M -$31.90M -$46.31M
YoY Change -9.63% -31.13% 4944.88%
Net Earnings / Revenue -173128.57% -265808.33% -463120.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$296.1K -$388.3K -$594.9K
COMMON SHARES
Basic Shares Outstanding 82.38M
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $198.9M $209.3M $358.6M
YoY Change -32.39% -41.63%
Cash & Equivalents $8.083M $31.40M $358.6M
Short-Term Investments $190.8M $177.9M
Other Short-Term Assets $275.0K $252.0K $1.700M
YoY Change -85.18%
Inventory
Prepaid Expenses
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $205.1M $214.5M $360.3M
YoY Change -31.05% -40.46%
LONG-TERM ASSETS
Property, Plant & Equipment $18.91M $16.48M $1.414M
YoY Change 242.31% 1065.13%
Goodwill
YoY Change
Intangibles $5.086M $5.948M $7.164M
YoY Change -30.25% -16.97%
Long-Term Investments $87.60M $94.70M $0.00
YoY Change 58.98%
Other Assets $788.0K $862.0K $1.326M
YoY Change -42.02% -34.99%
Total Long-Term Assets $112.4M $117.9M $9.904M
YoY Change 62.1% 1090.54%
TOTAL ASSETS
Total Short-Term Assets $205.1M $214.5M $360.3M
Total Long-Term Assets $112.4M $117.9M $9.904M
Total Assets $317.5M $332.4M $370.2M
YoY Change -13.45% -10.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.045M $2.245M $4.947M
YoY Change 94.0% -54.62%
Accrued Expenses $5.864M $5.910M $1.126M
YoY Change 127.73% 424.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.55M $10.20M $6.683M
YoY Change 104.18% 52.63%
LONG-TERM LIABILITIES
Long-Term Debt $2.000M $2.400M $0.00
YoY Change
Other Long-Term Liabilities $240.0K $22.00K $600.0K
YoY Change -96.33%
Total Long-Term Liabilities $240.0K $22.00K $600.0K
YoY Change -96.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.55M $10.20M $6.683M
Total Long-Term Liabilities $240.0K $22.00K $600.0K
Total Liabilities $24.08M $21.52M $7.260M
YoY Change 121.84% 196.42%
SHAREHOLDERS EQUITY
Retained Earnings -$387.1M -$358.9M -$172.7M
YoY Change 54.59% 107.78%
Common Stock $680.8M $669.6M $535.7M
YoY Change 12.23% 25.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $293.4M $310.9M $362.9M
YoY Change
Total Liabilities & Shareholders Equity $317.5M $332.4M $370.2M
YoY Change -13.45% -10.21%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income -$24.24M -$31.90M -$46.31M
YoY Change -9.63% -31.13% 4944.88%
Depreciation, Depletion And Amortization $1.840M $300.0K -$10.00K
YoY Change 275.51% -3100.0% -120.0%
Cash From Operating Activities -$10.75M -$10.68M -$4.200M
YoY Change -1.83% 154.29% 491.55%
INVESTING ACTIVITIES
Capital Expenditures -$1.360M -$3.080M -$650.0K
YoY Change 43.16% 373.85% 182.61%
Acquisitions
YoY Change
Other Investing Activities -$7.100M $9.930M $0.00
YoY Change -95.85%
Cash From Investing Activities -$8.460M $6.850M -$650.0K
YoY Change -95.08% -1153.85% 182.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.100M -2.990M 243.1M
YoY Change -1466.67% -101.23% 186884.62%
NET CHANGE
Cash From Operating Activities -10.75M -10.68M -4.200M
Cash From Investing Activities -8.460M 6.850M -650.0K
Cash From Financing Activities -4.100M -2.990M 243.1M
Net Change In Cash -23.31M -6.820M 238.2M
YoY Change -87.25% -102.86% -29511.11%
FREE CASH FLOW
Cash From Operating Activities -$10.75M -$10.68M -$4.200M
Capital Expenditures -$1.360M -$3.080M -$650.0K
Free Cash Flow -$9.390M -$7.600M -$3.550M
YoY Change -6.1% 114.08% 639.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q3 us-gaap Investment Income Net
InvestmentIncomeNet
81000
us-gaap Operating Income Loss
OperatingIncomeLoss
-99356000
CY2016Q3 us-gaap Investment Income Net
InvestmentIncomeNet
795000
us-gaap Operating Income Loss
OperatingIncomeLoss
-208952000
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
82375489
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
175908000
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7292000
CY2015Q4 us-gaap Assets
Assets
366849000
CY2015Q4 nk Build To Suit Lease Liability Noncurrent
BuildToSuitLeaseLiabilityNoncurrent
2468000
CY2016Q3 nk Financing Obligation Noncurrent
FinancingObligationNoncurrent
2390000
CY2015Q4 nk Financing Obligation Noncurrent
FinancingObligationNoncurrent
0
CY2016Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2488000
CY2015Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
845000
CY2016Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
192000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
228000
CY2016Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
883000
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
22000
CY2016Q3 us-gaap Liabilities
Liabilities
21520000
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
8000
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
669624000
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
135000
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-358876000
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
310891000
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
332411000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-32775000
us-gaap Interest Expense
InterestExpense
0
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
405000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.07
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
77837586
CY2015Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
0
CY2015Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
78000
CY2016Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-289000
CY2016Q3 us-gaap Assets
Assets
332411000
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2245000
CY2016Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5910000
CY2016Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
177852000
CY2016Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1853000
CY2016Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
94655000
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16475000
CY2016Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5948000
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
862000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1003000
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46312000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-96994000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-31897000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1101000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-210053000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-423000
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
82154219
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
46467000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
32787000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
201810000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
79678000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-250376000
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1165000
CY2015Q4 us-gaap Liabilities
Liabilities
10854000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
8000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
606555000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-192000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
355995000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
366849000
CY2016Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
48000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
119000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2362000
us-gaap Net Income Loss
NetIncomeLoss
-96571000
us-gaap Net Income Loss
NetIncomeLoss
-210054000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.18
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
82019203
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
89000
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
64000
us-gaap Interest Expense
InterestExpense
29000
us-gaap Investment Income Net
InvestmentIncomeNet
146000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
826000
CY2015Q3 us-gaap Interest Expense
InterestExpense
0
us-gaap Investment Income Net
InvestmentIncomeNet
2302000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1366000
CY2015Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
60000
CY2016Q3 us-gaap Interest Expense
InterestExpense
29000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-46312000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46312000
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.59
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
145000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
506000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68316004
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
327000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
0
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32186000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-96244000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41810000
us-gaap Operating Expenses
OperatingExpenses
209174000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-46457000
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-52000
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31949000
CY2016Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-241000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7364000
us-gaap Operating Expenses
OperatingExpenses
99386000
dei Document Period End Date
DocumentPeriodEndDate
2016-09-30
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
327000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-210054000
CY2016Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
dei Trading Symbol
TradingSymbol
NK
dei Entity Registrant Name
EntityRegistrantName
NANTKWEST, INC.
dei Entity Central Index Key
EntityCentralIndexKey
0001326110
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q3 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
288983000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
800000
CY2016Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
38400000
CY2016Q3 nk Prepaid Services
PrepaidServices
1866000
CY2015Q4 nk Prepaid License Fees
PrepaidLicenseFees
101000
CY2015Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1359000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
367000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0
nk Non Cash Interest Income Expense From Operating Activities
NonCashInterestIncomeExpenseFromOperatingActivities
273000
nk Change In Accounting Principle Forfeiture Adjustment
ChangeInAccountingPrincipleForfeitureAdjustment
0
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
62586000
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
592000
nk Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
41000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
11898000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1768000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
981000
us-gaap Share Based Compensation
ShareBasedCompensation
62586000
us-gaap Share Based Compensation
ShareBasedCompensation
189815000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-423000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-57000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-18000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1567000
nk Non Cash Interest Income Expense From Operating Activities
NonCashInterestIncomeExpenseFromOperatingActivities
0
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
118000
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
133000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1380000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1463000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-75000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1193000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
321000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3815000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2454000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
984000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
501000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
1225000
nk Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
1650000
nk Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
345000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-15000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-106000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-27840000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14361000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5202000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1286000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1818000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
207891000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
107885000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-105208000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3104000
nk Proceeds From Debt And Equity Offerings Net Of Issuance Costs
ProceedsFromDebtAndEquityOfferingsNetOfIssuanceCosts
0
nk Proceeds From Debt And Equity Offerings Net Of Issuance Costs
ProceedsFromDebtAndEquityOfferingsNetOfIssuanceCosts
316189000
nk Repayments Of Financing Obligations
RepaymentsOfFinancingObligations
10000
nk Repayments Of Financing Obligations
RepaymentsOfFinancingObligations
0
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
132000
nk Proceeds From Exercise Of Stock Options And Warrants
ProceedsFromExerciseOfStockOptionsAndWarrants
1044000
nk Proceeds From Exercise Of Stock Options And Warrants
ProceedsFromExerciseOfStockOptionsAndWarrants
8183000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
11898000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4798000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
592000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2415000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-11456000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
317027000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
0
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-50000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-144504000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
299512000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59104000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
358616000
us-gaap Interest Paid Net
InterestPaidNet
29000
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6000
nk Estimated Fair Market Value Of Building Under Build To Suit Lease
EstimatedFairMarketValueOfBuildingUnderBuildToSuitLease
5139000
nk Estimated Fair Market Value Of Building Under Build To Suit Lease
EstimatedFairMarketValueOfBuildingUnderBuildToSuitLease
2740000
nk Noncash Lease Incentive
NoncashLeaseIncentive
239000
nk Noncash Lease Incentive
NoncashLeaseIncentive
0
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
1092000
nk Cashless Exercise Of Stock Options And Warrants
CashlessExerciseOfStockOptionsAndWarrants
456000
nk Cashless Exercise Of Stock Options And Warrants
CashlessExerciseOfStockOptionsAndWarrants
1773000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including those related to the valuation of warrants, stock-based compensation, the valuation allowance for deferred tax assets, preclinical and clinical trial accruals, and the valuation of build-to-suit lease assets. The Company bases its estimates on historical experience and on various other market-specific and relevant assumptions that it believes to be reasonable under the circumstances. Actual results could differ from those estimates.</p></div>
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25152341
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28121031
CY2015Q4 nk Prepaid Services
PrepaidServices
631000
CY2016Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
1185000
CY2015Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
911000
CY2016Q3 us-gaap Prepaid Insurance
PrepaidInsurance
737000
CY2015Q4 us-gaap Prepaid Insurance
PrepaidInsurance
466000
CY2016Q3 nk Prepaid License Fees
PrepaidLicenseFees
462000
CY2016Q3 nk Prepaid Legal Fees
PrepaidLegalFees
350000
CY2015Q4 nk Prepaid Legal Fees
PrepaidLegalFees
350000
CY2016Q3 us-gaap Prepaid Rent
PrepaidRent
287000
CY2015Q4 us-gaap Prepaid Rent
PrepaidRent
0
CY2016Q3 us-gaap Due From Related Parties
DueFromRelatedParties
76000
CY2015Q4 us-gaap Due From Related Parties
DueFromRelatedParties
217000
CY2016Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
0
CY2015Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
646000
CY2016Q3 us-gaap Other Assets Current
OtherAssetsCurrent
252000
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
0
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17071000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5690000
CY2016Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
582400
CY2016Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
335440
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
596000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
167000
CY2016Q3 nk Equipment Not Placed In Service
EquipmentNotPlacedInService
533000
CY2015Q4 nk Equipment Not Placed In Service
EquipmentNotPlacedInService
624000
CY2016Q3 nk License Fees
LicenseFees
192000
CY2015Q4 nk License Fees
LicenseFees
0
CY2016Q3 us-gaap Security Deposit
SecurityDeposit
137000
CY2015Q4 us-gaap Security Deposit
SecurityDeposit
344000
CY2016Q3 nk Software License And Implementation Costs
SoftwareLicenseAndImplementationCosts
0
CY2015Q4 nk Software License And Implementation Costs
SoftwareLicenseAndImplementationCosts
391000
CY2016Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1622000
CY2016Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1469000
CY2016Q3 us-gaap Construction Payable Current
ConstructionPayableCurrent
990000
CY2015Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
132000
CY2016Q3 nk Accrued Preclinical And Clinical Trial Costs
AccruedPreclinicalAndClinicalTrialCosts
866000
CY2015Q4 nk Accrued Preclinical And Clinical Trial Costs
AccruedPreclinicalAndClinicalTrialCosts
0
CY2016Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
814000
CY2015Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
348000
CY2016Q3 nk Accrued Franchise And Property Taxes
AccruedFranchiseAndPropertyTaxes
14000
CY2015Q4 nk Accrued Franchise And Property Taxes
AccruedFranchiseAndPropertyTaxes
225000
CY2016Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
135000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
144000
CY2016Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1371000
CY2015Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
81000
us-gaap Investment Income Interest
InvestmentIncomeInterest
3802000
us-gaap Investment Income Interest
InvestmentIncomeInterest
146000
CY2016Q3 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-625000
CY2015Q3 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
0
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-1567000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
0
CY2016Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
49000
CY2015Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
67000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2016Q3 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2015Q3 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
nk Available For Sale Securities Maturity Period
AvailableForSaleSecuritiesMaturityPeriod
P5Y
CY2016Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
288659000
CY2016Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
430000
CY2016Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
106000
CY2016Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
288983000
CY2016Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
102465000
us-gaap Available For Sale Securities Continuous Unrealized Loss Position Aggregate Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses
106000
CY2015Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
191484000
CY2016Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
800000
CY2015Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
700000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2200000
CY2016Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
365440
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1594040
CY2016Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
38100000
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
28000000
CY2016Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
300000
CY2016Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
346200
CY2016Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
30000
CY2016Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1594040
CY2016Q1 nk Stock Repurchased During Period Per Share Value
StockRepurchasedDuringPeriodPerShareValue
8.50
CY2016Q2 nk Stock Repurchased During Period Per Share Value
StockRepurchasedDuringPeriodPerShareValue
6.77
CY2016Q2 nk Stock Repurchased During Period Per Share Value
StockRepurchasedDuringPeriodPerShareValue
7.56
CY2016Q3 nk Stock Repurchased During Period Per Share Value
StockRepurchasedDuringPeriodPerShareValue
7.01
CY2016Q3 nk Stock Repurchased During Period Per Share Value
StockRepurchasedDuringPeriodPerShareValue
7.40
nk Stock Repurchased During Period Per Share Value
StockRepurchasedDuringPeriodPerShareValue
7.45
CY2016Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
300000
CY2016Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
646200
CY2016Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1228600
CY2016Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1564040
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
189815000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
31000000
CY2012Q2 nk Percentage Of Outstanding Shares Acquired
PercentageOfOutstandingSharesAcquired
0.222
CY2012Q2 nk Business Acquisition Percentage Of Fully Diluted Shares Acquired
BusinessAcquisitionPercentageOfFullyDilutedSharesAcquired
0.174
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.00
CY2016Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
47500000
CY2016Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
45100000
CY2016Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
40700000
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18669000
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
38994000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
62586000
CY2016Q1 nk Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Additional Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationAdditionalCompensationCost
27000000
CY2012Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
57000
CY2012Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
200000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
100000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
200000
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0

Files In Submission

Name View Source Status
0001564590-16-028905-index-headers.html Edgar Link pending
0001564590-16-028905-index.html Edgar Link pending
0001564590-16-028905.txt Edgar Link pending
0001564590-16-028905-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nk-10q_20160930.htm Edgar Link pending
nk-20160930.xml Edgar Link completed
nk-20160930.xsd Edgar Link pending
nk-20160930_cal.xml Edgar Link unprocessable
nk-20160930_def.xml Edgar Link unprocessable
nk-20160930_lab.xml Edgar Link unprocessable
nk-20160930_pre.xml Edgar Link unprocessable
nk-ex101_159.htm Edgar Link pending
nk-ex311_172.htm Edgar Link pending
nk-ex312_171.htm Edgar Link pending
nk-ex321_170.htm Edgar Link pending
nk-ex322_169.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending